SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-22-005765
Filing Date
2022-07-28
Accepted
2022-07-28 20:04:46
Documents
2
Period of Report
2022-07-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1776
2 POA_TRIPURANENI poa_tripuraneni.txt EX-24 4625
  Complete submission text file 0001562180-22-005765.txt   7786
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Tripuraneni Radhika (Reporting) CIK: 0001761114 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39926 | Film No.: 221116840

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences